CLINICAL_TRIALS trial_result · 2010-09-10

Clinical Trial Update: Safety and Efficacy of GTS21 in Adults With Attention-deficit Hyperactivity Disorder [Phase 1, Phase 2]

Phase 1/2 clinical trial evaluating the safety and efficacy of GTS-21 in adults with ADHD; results were posted in 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: CoMentis | Conditions: Attention Deficit Hyperactivity Disorder | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2010-09-10